Cargando…

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers

The transcriptional coactivator YAP1 controls the balance between cell proliferation and apoptosis. YAP1 overexpression is linked to poor prognosis in many cancer types, yet its role in prostate cancer is unknown. Here, we applied YAP1 immunohistochemistry to a tissue microarray containing 17,747 cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marx, Andreas, Schumann, Aljoscha, Höflmayer, Doris, Bady, Elena, Hube-Magg, Claudia, Möller, Katharina, Tsourlakis, Maria Christina, Steurer, Stefan, Büscheck, Franziska, Eichenauer, Till, Clauditz, Till S., Graefen, Markus, Simon, Ronald, Sauter, Guido, Izbicki, Jakob R., Huland, Hartwig, Heinzer, Hans, Haese, Alexander, Schlomm, Thorsten, Bernreuther, Christian, Lebok, Patrick, Polonski, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265544/ https://www.ncbi.nlm.nih.gov/pubmed/32488048 http://dx.doi.org/10.1038/s41598-020-65772-w

Ejemplares similares

Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)

Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
por: Steurer, Stefan, et al.
Publicado: (2019)

Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
por: Steurer, Stefan, et al.
Publicado: (2019)

SNW1 is a prognostic biomarker in prostate cancer
por: Höflmayer, Doris, et al.
Publicado: (2019)

Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer
por: Marx, Andreas, et al.
Publicado: (2020)

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer
por: Weidemann, Sören A., et al.
Publicado: (2019)

Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
por: Fraune, Christoph, et al.
Publicado: (2020)

Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions
por: Bernreuther, Christian, et al.
Publicado: (2020)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancer
por: Eichenauer, Till, et al.
Publicado: (2019)

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
por: Luebke, Andreas M., et al.
Publicado: (2019)

Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer
por: Schroeder, Cornelia, et al.
Publicado: (2019)

VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy
por: Tsourlakis, Maria Christina, et al.
Publicado: (2015)

Deletion of 18q is a strong and independent prognostic feature in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2016)

Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
por: Möller, Katharina, et al.
Publicado: (2020)

Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer
por: Höflmayer, Doris, et al.
Publicado: (2019)

Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer
por: Freytag, Morton, et al.
Publicado: (2020)

Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues
por: Bonk, Sarah, et al.
Publicado: (2019)

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
por: Melling, Nathaniel, et al.
Publicado: (2015)

High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer
por: Melling, Nathaniel, et al.
Publicado: (2017)

Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer
por: Jacobsen, Frank, et al.
Publicado: (2017)

Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer
por: Burdelski, Christoph, et al.
Publicado: (2017)

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
por: Heinrich, Marie-Christine, et al.
Publicado: (2018)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
por: Burdelski, Christoph, et al.
Publicado: (2015)

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2018)

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases
por: Brandi, Franziska, et al.
Publicado: (2018)

Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence
por: Kind, Simon, et al.
Publicado: (2020)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
por: Kluth, Martina, et al.
Publicado: (2018)

The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
por: Burdelski, Christoph, et al.
Publicado: (2015)

Deletion of 8p is an independent prognostic parameter in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2016)

FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors
por: Dum, David, et al.
Publicado: (2022)

Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers()
por: Burdelski, Christoph, et al.
Publicado: (2017)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours
por: Meiners, Jan, et al.
Publicado: (2021)

Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland
por: Gorbokon, Natalia, et al.
Publicado: (2023)

Large-Scale Tissue Microarray Evaluation Corroborates High Specificity of High-Level Arginase-1 Immunostaining for Hepatocellular Carcinoma
por: Lennartz, Maximilian, et al.
Publicado: (2021)

Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients
por: Tsourlakis, Maria-Christina, et al.
Publicado: (2016)

Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas
por: Uhlig, Ria, et al.
Publicado: (2022)

Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma
por: Dwertmann Rico, Sebastian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ca0cvpeibgkpe8eb6dm1u65nfe